Aidian Duo Tablets 12.5/850 Milligrams (Empagliflozin, Metformin Hydrochloride)
Empagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Anguk Pharmaceutical Co., Ltd.
MFDS item code 202302582 · Approved 2023.08.30
Improvement of glycemic control in adults with type 2 diabetes mellitus
This medication is used to improve blood sugar control in adult patients with Type 2 diabetes who are following meal plans and exercise regimens. It is particularly important to administer in conjunction with expert advice for adult Type 2 diabetes patients with inadequate blood sugar control and a history of cardiovascular disease. This medication aids in blood sugar management and contributes to improving the patient's health.
The recommended dose of this medicine is 1 tablet twice daily. The dose should be determined based on each patient’s current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients who do not achieve adequate glycemic control with metformin alone or in combination with other medicines such as insulin, the recommended dose is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient’s current dose of metformin. If empagliflozin 10 mg (total daily dose) is well tolerated and additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching to this medicine from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin should receive their current doses of empagliflozin and metformin. When this medicine is administered concomitantly with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 4. Adverse Reactions and 6. Drug Interactions). This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If you miss a dose of this medicine, take it as soon as you remember. However, do not take a double dose at one time; if this occurs, skip the missed dose. No dose adjustment is necessary for patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who do not have other conditions that may increase the risk of lactic acidosis. In these patients, the starting dose of metformin is 500 mg or 850 mg once daily; therefore, treatment should be initiated with the individual components, empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this medicine is 1000 mg, which may be given as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months (see Precautions for Use, 3. Patients Requiring Caution, item 1)). If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, this medicine should be discontinued immediately (see Precautions for Use, 2. Patients Who Must Not Take This Medicine, item 2)). In patients aged 75 years or older, renal function and the risk of volume depletion should be considered.
This medication is an antidiabetic agent that helps control blood sugar. However, it may cause a rare but serious side effect called lactic acidosis; therefore, it should not be used in patients with impaired kidney function or those with severe infections, dehydration, etc. Additionally, when taken alongside other antidiabetic medications such as insulin or sulfonylureas, there is a risk of hypoglycemia, so caution is advised. Patients with moderate to severe renal impairment or conditions such as acute myocardial infarction, shock, or heart failure should refrain from using this medication. Prior to and after using iodinated contrast agents for tests, the administration of this medication should be temporarily discontinued and resumed only after kidney function is verified to be normal. Women who are pregnant or may become pregnant, as well as nursing mothers, are advised against using this medication. Regular kidney function and blood tests must be performed during the course of treatment, especially for elderly patients or those with compromised kidney function. This medication increases urine output, which may lead to fluid loss, so patients at risk for dehydration or hypotension should be monitored closely. Furthermore, there is a possibility of developing genital infections or urinary tract infections; hence, immediate consultation with healthcare professionals is required if symptoms arise. Alcohol consumption should be avoided during the course of this medication, and the risk of hypoglycemia may increase following irregular meals or vigorous exercise. In preparation for surgery or during acute illness, it is advisable to temporarily suspend this medication and resume it post-recovery. This medication is not recommended for children, and dosage adjustments should be made according to renal function without exceeding the maximum dose in elderly patients. In cases of overdose, hemodialysis may be necessary, and immediate medical attention should be sought. Finally, this medication should be stored out of the reach of children and retained in its original container for safety.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. The storage temperature should be maintained between 1 to 30 degrees Celsius at room temperature.
Pinkish-white, biconvex, elliptical film-coated tablet
60 tablets/box [10 tablets/PTP X 6], 10 tablets/box [10 tablets/PTP X 1], 60 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Empagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Anguk Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.